Sanofi – Group report and key figures
A REPORT PRESENTED THROUGH SUMMARY SLIDES OF GROUP'S OPERATIONS
A DETAILED HISTORY OF THE GROUP'S FINANCIAL PERFORMANCE BETWEEN 2018 AND 2023
AN OVERVIEW OF THE GROUP'S MAJOR BUSINESS STRATEGIES
A MEDIUM-TERM OUTLOOK FOR OPPORTUNITIES AND THREATS
650 €
WHAT IS THE GROUP'S FINANCIAL SITUATION ?
The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.
WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?
Drive growth through organic and inorganic measures
Extend R&D capabilities by tapping resources outside the company
Raise operating performance
WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?
Through a SWOT analysis, this report also provides an overview of the group's strengths (global leader in vaccines and diabetes treatments, etc.) and weaknesses (heavy dependence on one treatment: Dupixent, etc.).
Exploit the entire Xerfi content library (1,000 studies, 10,000 videos, and hundreds of articles) to produce market research, competitive intelligence, and strategic insights using simple prompts.
Detailed plan
Presentation
Segments
SWOT
Related reports
ACCESS THE REPORT
